I still think this Canine POC trial is low hanging fruit for the company and should restore some confidence.
It isn't the only thing we have to look forward to as there are hints of something commercial coming with this change in narrative on their website under the technology tab.
"Botanix is currently actively working with pharmaceutical partners who are using the Permetrex™ delivery system."
It would all be commercial in confidence at this stage but whatever sandpit they are playing in, you can imagine it will be big given the ties this company has.
I still think this Canine POC trial is low hanging fruit for the...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.005(2.04%) |
Mkt cap ! $393.7M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.5¢ | 24.5¢ | $823.6K | 3.305M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 292257 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 67065 | 3 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
25.0¢ |
Change
0.005 ( 3.22 %) |
||||
| Open | High | Low | Volume | ||
| 24.5¢ | 25.5¢ | 24.5¢ | 1596484 | ||
| Last updated 15.57pm 03/05/2024 ? | |||||
| BOT (ASX) Chart |